A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF DARVYADI VARTI AND COMBINATION OF CLINDAMYCIN PESSARY AND CLOTRIMAZOLE IN THE MANAGEMENT OF YONIGATA SHWETASTRAVA leucorrhoea

Randomized Controlled Clinical Trial to Evaluate the Efficacy of Darvyadi Varti Compared with a Combination of Clindamycin Pessary and Clotrimazole in the Management of Yonigata Shwetastrava Leucorrhoea - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106396

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age between 20- 45 years married female participants complaining of vaginal discharge. Participants having cervical erosion. Participants complaining of per vaginal white discharge with itching at vaginal area and staining of undergarments.

Exclusion criteria

Exclusion criteria: Pregnant women known case of sexually transmitted diseases Known case of anaemia Known case of diabetes mellitus known case of Serology positive participantsfor HIV, HbSAg, VDRL known case of Participants with cervical/ vaginal/ endometrial malignancy known case of Participants with cervical polyp

Design outcomes

Primary

Measure	Time frame
decrease in symptoms of shwetastrava and kandu symptomsTimepoint: 5 day	—

Secondary

Measure	Time frame
decrease in symptoms of shwetastrava symptomsTimepoint: 7 day	—

Countries

India

Contacts

Public ContactDr Pradeep Manmathrao Musale

Tilak Ayurved Mahavidyalaya

dr.musale@hotmail.com9225632451

Outcome results